Profile data is unavailable for this security.
About the company
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
- Revenue in USD (TTM)178.00k
- Net income in USD-2.80m
- Incorporated1992
- Employees4.00
- LocationGuided Therapeutics IncSuite 300, 4955 Avalon Ridge PkwyNORCROSS 30071United StatesUSA
- Phone+1 (770) 242-8723
- Fax+1 (770) 242-8639
- Websitehttps://www.guidedinc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harvard Bioscience Inc | 87.37m | -53.84m | 26.68m | 330.00 | -- | 1.89 | -- | 0.3053 | -1.22 | -1.22 | 1.98 | 0.3156 | 0.8352 | 1.58 | 7.01 | 264,760.60 | -51.46 | -4.48 | -81.52 | -5.47 | 56.94 | 57.18 | -61.62 | -6.18 | 0.4081 | -0.5686 | 0.7071 | -- | -16.14 | -4.12 | -263.25 | -- | 21.83 | -- |
| Femasys Inc | 2.06m | -19.80m | 28.93m | 69.00 | -- | 5.14 | -- | 14.03 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| Vaso Corp | 89.11m | 2.59m | 30.44m | 298.00 | 11.78 | 1.08 | 9.19 | 0.3416 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| Myomo Inc | 41.64m | -12.02m | 30.94m | 184.00 | -- | 2.12 | -- | 0.743 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Guided Therapeutics Inc | 178.00k | -2.80m | 32.60m | 4.00 | -- | -- | -- | 183.12 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| TELA Bio Inc | 77.06m | -39.00m | 33.52m | 209.00 | -- | 19.84 | -- | 0.435 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 33.62m | 117.00 | 57.55 | -- | -- | 6.51 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 34.24m | 18.00 | -- | 4.80 | -- | 2.83 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| Vivos Inc | 48.63k | -3.01m | 34.81m | 10.00 | -- | 15.97 | -- | 715.80 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Modular Medical Inc | 0.00 | -24.22m | 35.60m | 54.00 | -- | 3.20 | -- | -- | -0.5081 | -0.5081 | 0.00 | 0.1434 | 0.00 | -- | -- | 0.00 | -222.79 | -171.42 | -294.38 | -207.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.75 | -- | 57.07 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 35.92m | 10.00 | -- | 4.45 | -- | 38.70 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| Precision Optics Corporation Inc | 21.58m | -6.11m | 35.98m | 90.00 | -- | 3.29 | -- | 1.67 | -0.8505 | -0.8505 | 3.01 | 1.42 | 1.09 | 5.00 | 5.90 | 239,722.70 | -30.82 | -13.63 | -45.79 | -19.51 | 14.99 | 29.56 | -28.30 | -11.58 | 0.785 | -28.85 | 0.1375 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 37.85m | 61.00 | -- | 3.02 | -- | 2.57 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 39.16m | 64.00 | -- | 4.21 | -- | 13.16 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
| Cytosorbents Corp | 34.35m | -10.59m | 40.20m | 149.00 | -- | 4.46 | -- | 1.17 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| Precipio Inc | 22.80m | -1.25m | 41.17m | 54.00 | -- | 2.98 | 170.13 | 1.81 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
Data as of Feb 18 2026. Currency figures normalised to Guided Therapeutics Inc's reporting currency: US Dollar USD
5.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Auctus Fund Management LLCas of 18 Mar 2025 | 4.25m | 5.08% |
Data from 31 Jul 2025 - 31 Jul 2025Source: FactSet Research Systems Inc.
